NCT02145026 - A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS) | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

August 6, 2014

Primary Completion Date

April 9, 2019

Study Completion Date

April 9, 2019

Conditions

Myelodysplastic Syndromes

Interventions

DRUG

Epoetin beta

Epoetin beta 30,000 or 60,000 IU per week SC injection

Trial Locations (10)

King Chulalongkorn Memorial Hospital; Division of Hematology, Department of Medicine, Bangkok

Rajavithi Hospital; Medicine, Bangkok

Ramathibodi Hospital; Division of Hematology, Department of Medicine, Bangkok

Siriraj Hospital; Division of Hematology, Department of Medicine, Bangkok

Thammasart Chalermprakiert Hospital, Thammasart Uni; Hematology, Pathum Thani

Sapprasitthiprasong Hospital, Ubon Ratchathani

Khonkean Regional Hospital; Medicine, Khon Kaen

Srinagarind Hospital, Khon Kaen Uni ; Dept of Medicine, Khon Kaen

Chiang Mai Uni Hospital; Division of Hematology,Dept of Medicine,Faculty of Medicine, Chiang Mai

Naresaun University hospital, Phitsanulok

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY